Big Feelings: A Study on Children's Emotions in Therapy

Sponsor
University of Guelph
Study ID
NCT05637320
Status
Recruiting
Apply to this trial

Conditions

  • Anxiety Disorders
  • Child Behavior Disorders
  • Conduct Disorder
  • Depressive Disorder
  • Mood Disorders
  • Oppositional Defiant Disorder
  • Regulation, Emotion
  • Trauma and Stressor Related Disorders

Eligibility Criteria

Sex
ALL
Age
8 Years - 15 Years
Healthy Volunteers
Not accepted

Interventions

  • Modular Approach to Therapy for Children with Anxiety, Depression, Trauma or Conduct Problems — BEHAVIORAL
    The intervention arm will consist of a transdiagnostic psychotherapy program: The Modular Approach to Therapy for Children with Anxiety, Depression, Trauma, or Conduct Problems (MATCH-ADTC). MATCH draws from various domains of evidence-based treatment and consists of 33 treatment modules. There are several core module sequences for problem areas such as depression, anxiety, trauma, and disruptive behavior, and a clinician can utilize these sequences based on the primary concern of the presenting child. If an individual reports additional stressors or comorbid conditions, the clinician can modify the sequence of the modules to address these comorbidities. MATCH treatment is flexible and is tailored for each individual client.

Study Details

The goal of this clinical trial is to learn about how psychotherapy works for children and adolescents aged 8 - 15 with anxiety, depression, trauma, or disruptive behaviour. The main question it aims to answer is: • Is the biobehavioural regulation of negative emotion a transdiagnostic mechanism of treatment response in psychotherapy for children with anxiety, depression, trauma and/or disruptive behaviour? Children and their parents will be randomly assigned to an evidence-based, transdiagnostic treatment (the Modular Approach to Therapy for Children with Anxiety, Depression, Trauma, and Conduct Problems; MATCH-ADTC) or a waitlist control condition. Participants in both groups will complete a baseline assessment, weekly measures consisting of brief symptom scales and medication tracking, and quarterly assessments every 3 months. Following the intervention/waitlist period, our team will conduct post-test assessments. All assessments, except for the weekly surveys, will consist of symptom scales, clinical interviews, experimental tasks and physiological measures.

Key Dates

First listed
Dec 5, 2022
Start date
Oct 1, 2022
Status verified
Jan 2025
Primary completion
Dec 31, 2027
Completion
Dec 31, 2027

Study Design

Enrollment
202 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Intervention Arm
    Treatment will be administered to participants in this arm.
  • No Intervention: Control Arm
    No treatment will be administered to participants in this arm until post-test assessment has been completed.

Primary Outcome Measure

Change in parent-rated child psychopathology symptoms [ Time Frame: Change at quarterly (3 month intervals after pre-test), change at post-test (after completion of the waitlist or intervention treatment; an average range 4 - 6 months) ]

Central Contacts

Find similar trials

Nationwide
Depression trialsPsychiatry trialsMental health trialsBehavioral health trials

Related Studies